InsiderTrades.com logo
3 Potential Sky-High Performers
From Weekly Investor Alerts   |   Ad
Want to join a small community of investors looking for the next big winners in 2023?

These 3 Stocks are potential sky-high performers you should be watching heading into Monday.

Click Here for Names & Ticker Symbols.
>>>

LDX Insider Trading

Insider Ownership Percentage: 44.33%
Insider Buying (Last 12 Months): A$3,553.60
Insider Selling (Last 12 Months): A$0.00

Lumos Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Lumos Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lumos Diagnostics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/29/2021 11:06 AM ET

This chart shows the closing price history over time for LDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
3 Potential Sky-High Performers
From Weekly Investor Alerts   |   Ad
Want to join a small community of investors looking for the next big winners in 2023?

These 3 Stocks are potential sky-high performers you should be watching heading into Monday.

Click Here for Names & Ticker Symbols.
>>>

Lumos Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/2/2022Catherine RobsonInsiderBuy71,072A$0.05A$3,553.60
11/30/2022Bronwyn Le GriceInsiderExpiry11,138A$0.05A$545.76
6/30/2022Catherine RobsonInsiderIssued109,349A$0.19A$20,776.31
10/28/2021Robert SamburskyInsiderIssued24,000A$1.25A$30,000.00
See Full Table
3 Potential Sky-High Performers
From Weekly Investor Alerts   |   Ad
Want to join a small community of investors looking for the next big winners in 2023?

These 3 Stocks are potential sky-high performers you should be watching heading into Monday.

Click Here for Names & Ticker Symbols.
>>>

SEC Filings (Institutional Ownership Changes) for Lumos Diagnostics (ASX:LDX)

20.24% of Lumos Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Read More on Lumos Diagnostics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Lumos Diagnostics?

Lumos Diagnostics' top insider investors include:
  1. Bronwyn Le Grice (Insider)
  2. Catherine Robson (Insider)
  3. Robert Sambursky (Insider)
Learn More about top insider investors at Lumos Diagnostics.
The Ultimate Passive Income Play
From The Oxford Club   |   Ad
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>